Biodexa Pharmaceticals
Price & Volume
Stats
See more52W Range | $3.50-$122.50 |
Market Cap | $2.6M |
Shares Short | 13,762 |
Financials
See moreRevenue (12 Mos) | $83,000 |
Revenue Growth (YoY) | -64.1% |
Gross Profit (12 Mos) | -$4.4M |
Diluted EPS | -$75.50 |
About
CEO | Mr. Stephen A. Stamp |
CFO | Mr. Stephen A. Stamp |
Address | 1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |
